| __timestamp | Rhythm Pharmaceuticals, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 1213000 | 2999000 |
| Thursday, January 1, 2015 | 3425000 | 10393000 |
| Friday, January 1, 2016 | 6311000 | 15994000 |
| Sunday, January 1, 2017 | 9518000 | 26975000 |
| Monday, January 1, 2018 | 28080000 | 39509000 |
| Tuesday, January 1, 2019 | 36550000 | 48869000 |
| Wednesday, January 1, 2020 | 46125000 | 42510000 |
| Friday, January 1, 2021 | 68486000 | 46105000 |
| Saturday, January 1, 2022 | 92032000 | 50513000 |
| Sunday, January 1, 2023 | 117532000 | 51292000 |
Data in motion
In the competitive world of biotechnology, strategic spending on Selling, General, and Administrative (SG&A) expenses can be a key differentiator. Rhythm Pharmaceuticals, Inc. and Wave Life Sciences Ltd. have shown distinct patterns in their SG&A expenditures over the past decade.
From 2014 to 2023, Rhythm Pharmaceuticals saw a staggering increase in SG&A expenses, growing nearly 97 times from 2014 to 2023. In contrast, Wave Life Sciences experienced a more modest growth, with expenses increasing by about 17 times over the same period.
This divergence in spending could reflect differing strategic priorities or stages of growth. Rhythm's aggressive increase might indicate a focus on rapid expansion and market penetration, while Wave's steadier growth could suggest a more conservative approach. Understanding these patterns provides valuable insights into each company's operational strategies and market positioning.
Cost Management Insights: SG&A Expenses for Johnson & Johnson and Wave Life Sciences Ltd.
argenx SE and Rhythm Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Bio-Techne Corporation and Wave Life Sciences Ltd.
Selling, General, and Administrative Costs: Catalent, Inc. vs Rhythm Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Opthea Limited vs Wave Life Sciences Ltd.
Breaking Down SG&A Expenses: Alpine Immune Sciences, Inc. vs Wave Life Sciences Ltd.
Selling, General, and Administrative Costs: CymaBay Therapeutics, Inc. vs Rhythm Pharmaceuticals, Inc.
Comparing SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs Perrigo Company plc Trends and Insights
Rhythm Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Rhythm Pharmaceuticals, Inc. or Xencor, Inc.
PTC Therapeutics, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Bausch Health Companies Inc. vs Wave Life Sciences Ltd.